REAP Financial Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$83.7K Sell
1,070
-170
-14% -$13.7K 0.01% 236
2026
Q1
$107K Buy
1,240
+281
+29% +$26.9K 0.02% 195
2025
Q4
$92.1K Buy
959
+98
+11% +$9.52K 0.02% 213
2025
Q3
$82K Buy
861
+92
+12% +$8.46K 0.02% 212
2025
Q2
$67K Buy
769
+316
+70% +$26.8K 0.02% 227
2025
Q1
$40.7K Buy
453
+154
+52% +$13.8K 0.01% 231
2024
Q4
$23.9K Buy
299
+89
+42% +$7.71K 0.01% 272
2024
Q3
$18.9K Buy
210
+49
+30% +$4.12K ﹤0.01% 273
2024
Q2
$12.7K Sell
161
-13
-7% -$1.07K ﹤0.01% 306
2024
Q1
$15.2K Sell
174
-1,026
-86% -$87.6K ﹤0.01% 318
2023
Q4
$98.9K Buy
+1,200
New +$91.5K 0.03% 196

Other funds holding MDT

REAP Financial Group's MDT Position: Q2 2026 in Review

REAP Financial Group reduced its Medtronic (MDT) stake by 14% in Q2 2026, selling an estimated $13.7K and leaving 1,070 shares worth $83.7K. The position accounts for 0.01% of the portfolio, ranked #236.

REAP Financial Group first reported a position in MDT in Q4 2023 and has held it in 11 quarters since. The position peaked at $107K in Q1 2026. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • REAP Financial Group held 1,070 shares of Medtronic worth $83.7K as of Q2 2026.
  • REAP Financial Group sold 170 Medtronic shares in Q2 2026, an estimated $13.7K.
  • Medtronic made up 0.01% of REAP Financial Group's portfolio in Q2 2026, its #236 holding.
  • REAP Financial Group first reported a position in Medtronic in Q4 2023 and has held it in 11 quarters since.
  • REAP Financial Group's Medtronic position peaked at $107K in Q1 2026.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on REAP Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.